NXGL

1.31% -0.0083

Handel nachbörslich: .60 -0.0247 -3.95%

Nexgel Inc (NXGL)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nexgel Inc Stock (NXGL) Company Profile

Healthcare (1116)

215 702-8550

2150 CABOT BLVD WEST,, LANGHORNE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NXGL's Discussions on Twitter

Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NXGL Nexgel Inc	0.6247	5.15M	11.67M	-2.79M	-2.55M	-0.3783
ISRG Intuitive Surgical Inc	464.45	163.73B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	156.34	44.73B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.51	36.73B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	44.00	36.12B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	222.85	32.70B	5.40B	1.49B	1.78B	10.12

Nexgel Inc Aktie (NXGL) Neueste Nachrichten

Finanzdaten der Nexgel Inc-Aktie (NXGL)

Nexgel Inc (NXGL)

Nexgel Inc Stock (NXGL) Company Profile

Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD

Nexgel Inc Aktie (NXGL) Neueste Nachrichten

Shootin' the Bull about "has to" - barchart.com

NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Published on: 2026-04-01 05:28:13 - baoquankhu1.vn

NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative

NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - tradingview.com

Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - tradingview.com

NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan

NXGL PE Ratio & Valuation, Is NXGL Overvalued - intellectia.ai

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - marketscreener.com

NEXGEL Reschedules 2025 Financial Results Conference Call - GlobeNewswire

NEXGEL delays earnings call a week to add detail on Celularity deal - Stock Titan

Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN

Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn

How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn

NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN

Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn

Published on: 2026-03-28 04:45:25 - baoquankhu1.vn

Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - tradingview.com

NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - ad-hoc-news.de

3 Stocks Under $50 That Concern Us - Barchart.com

NEXGEL secures $1.8 million financing for potential acquisition - MSN

NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN

NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com

NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan

Oxford Industries Earnings: What To Look For From OXM - Barchart

NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World

NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo

Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn

Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn

NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo

NexGel (NXGL) Expected to Announce Earnings on Monday - defenseworld.net

NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria

UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com

NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal

NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada

NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart

NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com

NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire

Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan

Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan

Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget

NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada

NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks

Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks

NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView

Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan

Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView

NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative

Finanzdaten der Nexgel Inc-Aktie (NXGL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NXGL